Innovative Biotherapies, Inc.

Ann Arbor, MI Doing business as Innovative Bio-Therapies Inc.

UEI
T5BFF2BJ8SE3
CAGE
3S6E5
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
650 Avis Dr #300, Ann Arbor, MI 48108, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Innovative Biotherapies, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Cell directed immunomodulation therapy as a bridge to left ventricular device implantation in chronic heart failure… Grant · R44HL170779 National Heart Lung and Blood Institute $3,625,359
SCD-picc therapy for respiratory insufficiency associated with covid-19 in non-ICU settings - abstract. The selective… Grant · R43HL164239 National Heart Lung and Blood Institute $663,514
Assessment of a therapeutic device for treatment of acute lung injury using a combat-relevant porcine model Grant · W81XWH1610463 Medical Command $2,696,788
Phase 2 study of selective cytopheretic device for the treatment of pediatric patients with acute kidney injury Grant · R01FD005092 FDA Office of Acquisition and Grant Services $976,393
Biomimetic membrane device for therapeutic application in chronic heart failure Grant · R43HL118792 National Institutes of Health $655,205

Quick answers

What is Innovative Biotherapies, Inc.'s UEI?

Innovative Biotherapies, Inc.'s Unique Entity ID (UEI) in SAM.gov is T5BFF2BJ8SE3.

What is Innovative Biotherapies, Inc.'s CAGE code?

Innovative Biotherapies, Inc.'s CAGE code is 3S6E5.

Where is Innovative Biotherapies, Inc. located?

Innovative Biotherapies, Inc.'s physical address in SAM.gov is 650 Avis Dr #300, Ann Arbor, MI 48108, USA.

Is Innovative Biotherapies, Inc. registered in SAM.gov?

Yes. Innovative Biotherapies, Inc.'s SAM.gov registration is active through December 5, 2026.

What is Innovative Biotherapies, Inc.'s most recent federal award?

Innovative Biotherapies, Inc.'s most recent federal grant award is Cell directed immunomodulation therapy as a bridge to left ventricular device implantation in chronic heart failure… (R44HL170779), from National Heart Lung and Blood Institute, on June 1, 2024.

On GovTribe

See Innovative Biotherapies, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login